Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Research article

Alcohol use disorders and associated chronic disease – a national retrospective cohort study from France

Authors: Michaël Schwarzinger, Sophie Pascale Thiébaut, Sylvain Baillot, Vincent Mallet, Jürgen Rehm

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

Evidence on diseases caused by or associated with alcohol use disorders (AUDs) has been based on two meta-analyses including rather dated studies. The objective of this contribution was to estimate the risks of all-cause mortality and alcohol-attributable disease categories depending on a diagnosis of AUDs in a national sample for France.

Methods

In a national retrospective cohort study on all inpatient acute and rehabilitation care patients in Metropolitan France 2008–2012 (N = 26,356,361), AUDs and other disease categories were identified from all discharge diagnoses according to standard definitions, and we relied on in-hospital death for mortality (57.4% of all deaths).

Results

704,803 (2.7%) patients identified with AUDs had a threefold higher risk of death (HR = 2.98; 95% CI: 2.96–3.00) and died on average 12.2 years younger (men: 10.4, 95% CI: 10.3–10.5; women: 13.7, 95% CI: 13.6–13.9). AUDs were associated with significantly higher risks of hospital admission for all alcohol-attributable disease categories: digestive diseases, cancers (exception: breast cancer), cardiovascular diseases, dementia, infectious diseases, and injuries. Elevated risks were highest for liver diseases that were associated with about two-third of deaths in patients with AUDs (men: 64.3%; women: 71.1%).

Conclusions

AUDs were associated with marked premature mortality and higher risks of alcohol-attributable disease categories. Our results support the urgent need of measures to reduce the burden of AUDs.
Appendix
Available only for authorised users
Literature
1.
World Health Organization. Global status report on alcohol and health. Geneva, Switzerland: World Health Organization; 2014.
2.
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2016;388:1659–724.CrossRef
3.
World Health Organization. ICD-10 classification of mental and behavioural disorders: with glossary and diagnostic criteria for research. New York, N.Y: Churchill Livingstone; 1994.
4.
Rehm J, Shield KD, Gmel G, Rehm MX, Frick U. Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol. 2013;23:89–97.CrossRefPubMed
5.
Rehm J, Dawson D, Frick U, Gmel G, Roerecke M, Shield KD, et al. Burden of disease associated with alcohol use disorders in the United States Alcohol. Clin Exp Res. 2014;38:1068–77.CrossRef
6.
Rehm J, Marmet S, Anderson P, Gual A, Kraus L, Nutt DJ, et al. Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol. 2013;48:633–40.CrossRefPubMed
7.
Lachenmeier DW, Kanteres F, Rehm J. Epidemiology-based risk assessment using the benchmark dose/margin of exposure approach: the example of ethanol and liver cirrhosis. Int J Epidemiol. 2011;40:210–8.CrossRefPubMed
8.
Pflaum T, Hausler T, Baumung C, Ackermann S, Kuballa T, Rehm J, et al. Carcinogenic compounds in alcoholic beverages: an update. Arch Toxicol. 2016;90:2349–67.CrossRefPubMed
9.
Rehm J, Baliunas D, Borges GL, Graham K, Irving HM, Kehoe T, et al. The relation between different dimensions of alcohol consumption and burden of disease - an overview. Addiction. 2010;105:817–43.CrossRefPubMedPubMedCentral
10.
Shield KD, Parry C, Rehm J. Chronic diseases and conditions related to alcohol use. Alcohol Res. 2013;35:155–71.PubMed
11.
Rehm J, Gmel GE, Gmel G, Hasan OSM, Imtiaz S, Popova S, et al. The relationship between different dimensions of alcohol use and the burden of disease - an update. Addiction. 2017;112:968–1001.CrossRefPubMedPubMedCentral
12.
International Agency for Research on Cancer. Alcohol consumption and ethyl carbamate. Monograph 96 on the evaluation of carcinogenic risks to humans. Lyon, France: International Agency for Research on Cancer; 2010.
13.
Irving HM, Samokhvalov AV, Rehm J. Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP. 2009;10:387–92.PubMedPubMedCentral
14.
Roerecke M, Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med. 2014;12:182.CrossRefPubMedPubMedCentral
15.
Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau JM, Mont L, Rubin E. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med. 1989;320:409–15.CrossRefPubMed
16.
Samokhvalov AV, Irving HM, Rehm J. Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiov Prev R. 2010;17:706–12.CrossRef
17.
Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S, et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types--a systematic review and meta-analysis. BMC Public Health. 2010;10:258.CrossRefPubMedPubMedCentral
18.
Samokhvalov AV, Irving HM, Rehm J. Alcohol consumption as a risk factor for pneumonia: a systematic review and meta-analysis. Epidemiol Infect. 2010;138:1789–95.CrossRefPubMed
19.
Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry C, Lonnroth K, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. 2009;9:450.CrossRefPubMedPubMedCentral
20.
Cherpitel C, Ye Y, Bond J, Borges G, Autonoma M, Monteiro M, et al. Alcohol attributable fraction for injury morbidity from the dose-response relationship of acute alcohol consumption: emergency department data from 18 countries. Addiction. 2015;110:1724–32.CrossRefPubMedPubMedCentral
21.
Rehm J, Room R, Monteiro M, Gmel G, Graham K, Rehn N et al. Alcohol Use. In: Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. edn. Edited by Ezzati M, Lopez AD, Rodgers A, Murray CJL. Geneva, Switzerland: World Health Organization; 2004: 959–1109.
22.
Letenneur L. Moderate alcohol consumption and risk of developing dementia in the elderly: the contribution of prospective studies. Ann Epidemiol. 2007;17:S43–5.CrossRef
23.
Peters R, Peters J, Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing. 2008;37:505–12.CrossRefPubMed
24.
Gupta S, Warner J. Alcohol-related dementia: a 21st-century silent epidemic? Br J Psychiatry. 2008;193:351–3.CrossRefPubMed
25.
Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y. Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health. 2014;24:643.CrossRef
26.
Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386:2287–323.CrossRefPubMed
27.
28.
Roerecke M, Rehm J. Cause-specific mortality risk in alcohol use disorder treatment patients: a systematic review and meta-analysis. Int J Epidemiol. 2014;43:906–19.CrossRefPubMed
29.
30.
31.
Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol. 1997;145:72–80.CrossRefPubMed
32.
Roerecke M, Rehm J. Alcohol use disorders and mortality - a systematic review and meta-analysis. Addiction. 2013;108:1562–78.CrossRefPubMed
33.
Westman J, Wahlbeck K, Laursen TM, Gissler M, Nordentoft M, Hallgren J, et al. Mortality and life expectancy of people with alcohol use disorder in Denmark, Finland and Sweden. Acta Psychiat Scand. 2015;131:297–306.CrossRefPubMed
34.
Rehm J, Allamani A, Aubin HJ, Della Vedova R, Elekes Z, Frick U, et al. People with alcohol use disorders in specialized care in eight different European countries. Alcohol Alcohol. 2015;50:310–8.CrossRefPubMed
35.
Rehm J, Allamani A, Elekes Z, Jakubczyk A, Landsmane I, Manthey J, et al. General practitioners recognizing alcohol dependence: a large cross-sectional study in six European countries. Ann Fam Med. 2015;13:28–32.CrossRefPubMedPubMedCentral
36.
Thomasson H. Gender Differences in Alcohol Metabolism. In: Recent Developments in Alcoholism. Volume 12, edn. Edited by Galanter M, Begleiter H, Deitrich R, Gallant D, Goodwin D, Gottheil E, Paredes A, Rothschild M, Van Thiel D, Edwards H: Springer US; 1995: 163–179.
37.
38.
39.
Schomerus G, Holzinger A, Matschinger H, Lucht M, Angermeyer MC. Public attitudes towards alcohol dependence an overview. Psychiatr Prax. 2010;37:111–8.CrossRefPubMed
40.
Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al. Use of mental health services in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiat Scand. 2004;109:47–54.CrossRef
41.
Rehm J, Anderson P, Barry J, Dimitrov P, Elekes Z, Feijão F, et al. Prevalence of and potential influencing factors for alcohol dependence in Europe. Eur Addict Res. 2015;21:6–18.CrossRefPubMed
42.
Boyle P. Alcohol consumption and breast cancer risk. In: Alcohol: Science, Policy, and Public Health. edn. Edited by Boyle P, Bofetta P, Lowenfels AB, Burns H, Brawley O, Zatonski W, Rehm J. Oxford, U.K.: Oxford University Press; 2013: 234–240.
43.
Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2015;112:580–93.CrossRefPubMed
44.
Hamajima N, Hirose K, Tajima K, Rohan T, Calle E, Heath C, et al. Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer. 2002;87:1234–45.CrossRefPubMed
45.
Roerecke M, Gual A, Rehm J. Reduction of alcohol consumption and subsequent mortality in alcohol use disorders: systematic review and meta-analysis. J Clin Psychiatry. 2013;74:e1181–9.CrossRefPubMed
46.
Babor TF, Higgins-Biddle JC. Brief intervention - for hazardous and harmful drinking. A manual for use in primary care. World health Organization: Geneva, Switzerland; 2001.
47.
McQueen J, Howe TE, Allan L, Mains D, Hardy V. Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane Database Syst Rev. 2011;8:CD005191.
48.
Ragaisis KM. Alcohol screening in the acute care hospital. J Addict Nurs. 2004;15:171–5.CrossRef
49.
Anderson P, Bendtsen P, Spak F, Reynolds J, Drummond C, Segura L, et al. Improving the delivery of brief interventions for heavy drinking in primary health care: outcome results of the optimizing delivery of health care intervention (ODHIN) five-country cluster randomized factorial trial. Addiction. 2016;111:1935–45.CrossRefPubMed
50.
World Health Organization. Global strategy to reduce the harmful use of alcohol. Geneva: World Health Organization; 2010.
51.
Anderson P, Braddick F, Conrod P, Gual A, Hellman M, Matrai S, et al. The new governance of addictive substances and behaviours. Oxford, U.K.: Oxford University Press; 2017.CrossRef
Metadata
Title
Alcohol use disorders and associated chronic disease – a national retrospective cohort study from France
Authors
Michaël Schwarzinger
Sophie Pascale Thiébaut
Sylvain Baillot
Vincent Mallet
Jürgen Rehm
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-017-4587-y

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue

Research article

Processes, practices and influence: a mixed methods study of public health contributions to alcohol licensing in local government

Research article

Unhealthy food and non-alcoholic beverage advertising on children’s, youth and family free-to-air and digital television programmes in Thailand

Research article

Body and mind: retention in antiretroviral treatment care is improved by mental health training of care providers in Ethiopia

Study protocol

A school-based interdisciplinary approach to promote health and academic achievement among children in a deprived neighborhood: study protocol for a mixed-methods evaluation

Correction

Correction to: Acceptability of HIV self-sampling kits (TINY vial) among people of black African ethnicity in the UK: a qualitative study

Research article

Oral health literacy and oral health outcomes in an adult population in Brazil